Pathstone Family Office, LLC Roivant Sciences Ltd. Transaction History

Pathstone Family Office, LLC

  • $15.6 Billion
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 23, 2023
BUY
$0.51 - $4.84 $1,135 - $10,778
2,227 Added 6.14%
38,488 $123,000
Q3 2022

Nov 14, 2022
BUY
$0.51 - $4.84 $1,135 - $10,778
2,227 Added 6.14%
38,488 $124,000
Q2 2022

Oct 23, 2023
BUY
$2.81 - $4.84 $101,893 - $175,503
36,261 New
36,261 $147,000
Q2 2022

Aug 15, 2022
BUY
$2.81 - $4.84 $101,893 - $175,503
36,261 New
36,261 $148,000

Others Institutions Holding ROIV

# of Institutions
338
Shares Held
511M
Call Options Held
813K
Put Options Held
1.01M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.44B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email